Hypogonadism
Hypogonadism is a condition where the body doesn't produce enough testosterone, leading to symptoms like fatigue, reduced libido, and muscle weakness.
Testosterone Supplementation for Obese Men with Type 2 Diabetes
We are studying whether intramuscular testosterone can reduce liver fat in obese men with low testosterone and type 2 diabetes. This trial will also look at the long-term effects on metabolic health.
>2 yearsMonitoring phase (IV)Post-Trial Drug AccessInvestigational MedicinesInjectionDiabetologyEndocrinologyInternal Medicine
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Type 2 Diabetes Mellitus (T2DM)
Type 2 Diabetes Mellitus is a chronic condition that affects the way your body metabolizes sugar (glucose), leading to high blood sugar levels and symptoms like increased thirst and frequent urination.
Prediabetes
Prediabetes is a health condition where blood sugar levels are higher than normal but not yet high enough to be diagnosed as diabetes, often leading to symptoms like increased hunger and fatigue.
Overweight
Being overweight is defined as having a body mass index (BMI) between 25 and 29.9, which can lead to health issues like heart disease and diabetes.
Obesity
Obesity is a medical condition characterized by excessive body fat that increases the risk of health problems, including diabetes and heart disease.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 75 years old?
- Do you have type 2 diabetes or prediabetes?
- Are you currently taking any diabetes medications like Metformin, SGLT2 inhibitors, or DPP4 inhibitors?
- Have you had a heart attack or stroke in the last 12 months?
- Is your serum creatinine (kidney function marker from blood test) above 1.5 mg/dl?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Nebido
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Medical University Of Vienna
Department of Medicine III, Division of Endocrinology and Metabolism
Vienna, Austria
Sponsor: Medical University Of Vienna
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.